Amol Akhade: India made cervical cancer vaccine is non inferior to original made by MSD in phase 2/3 RCT

Amol Akhade, Consultant Medical Oncologist/Hematologist at Suyog Cancer Clinics, posted on Twitter:

“So India made cervical cancer vaccine ( Cervavac ) is non inferior to original made by MSD ( Gardasil ) in phase 2/3 RCT. It is less than Half as costly as Original. This will make cervical cancer vaccine more accessible and affordable, not only to LMICs but to HICs also.”

Source: Amol Akhade/Twitter